Oral Medications for Prostate Cancer: How Can Patients Achieve More Structured Home-Based Management?

Oral androgen receptor pathway inhibitors, abiraterone, and oral GnRH antagonists let eligible prostate cancer patients manage part of their treatment at home, supported by regular PSA, testosterone, and safety monitoring.

Top Stories

Latest Coverage

What Professional Services Do Online Pharmacies Provide?
With the development of digital healthcare and pharmaceutical services, online pharmacies are expanding beyond simply...
What Do RET and BRAF Gene Changes Mean in Thyroid Cancer?
What Do RET and BRAF Gene Changes Mean in Thyroid Cancer?
New Drug for Biliary Tract Cancer! A Japanese Innovation Enters China, Adding a New Variable to the Global FGFR Landscape
New Drug for Biliary Tract Cancer! A Japanese Innovation Enters China, Adding a New Variable to the Global FGFR Lands...
What Should You Pay Attention to When Purchasing Prescription Medicines? A Practical Guide You Should Read Before Buying Medicines Online
With the development of online healthcare and cross-border pharmaceutical services, more and more people are searchin...
Ensartinib Approved for Adjuvant Treatment of ALK-Positive NSCLC, Marking Another Step Forward for China's ALK Inhibitors
For patients with early-stage ALK-positive non-small cell lung cancer (NSCLC), surgery does not eliminate the risk of...
What Is Synthetic Lethality? How PARP Inhibitors Work in Cancer Treatment
In the field of precision oncology, synthetic lethality is an important concept that has helped shape new approaches ...

In-Depth Analysis


This site uses Just the Docs, a documentation theme for Jekyll.